– Disclaimer –

Invitrx Therapeutics, Inc. (Invitrx) and its distributor Medco Instruments, Inc. is NOT liable for the intended use of any of its products. Invitrx does not intend to define, suggest, alter or approve of any kind of “practice of medicine” performed by the administering physician(s) instead relying on the IND and/or Clinical Trial IRB to determine safe practices of use of the Cord Blood Stem Cell Product(s) (CBSC), Amniotic Fluid, Amniotic Tissue, Human Umbilical Cord Blood Plasma (hUCBP), Wharton’s Jelly, and Wharton’s Jelly (MSC). These products are for Research Use Only.


Umbilical cord blood stem cell treatment for a patient with psoriatic arthritis
Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial
Biological effects and mechanisms of action of mesenchymal stem cell therapy in chronic
obstructive pulmonary disease

Cord Blood Stem Cells: A Review of Potential Neurological Applications
Mesenchymal stem cell therapy for knee osteoarthritis.
Preliminary report of four patients

Human umbilical cord blood cells improve cardiac function after myocardial infarction
Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients with Active Rheumatoid Arthritis: Safety and Efficacy
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?
Parkinson’s Disease and Mesenchymal Stem Cells: Potential for Cell-Based Therapy
Administrations of human adult ischemia-tolerant mesenchymal
stem cells and factors reduce amyloid beta pathology in a mouse
model of Alzheimer’s disease

Stem cell transplantation therapy in Parkinson’s disease
Treatment of Diabetic Impotence with Umbilical Cord Blood Stem Cell Intracavernosal Transplant: Preliminary Report of 7 Cases
Invitra CBSC™ – Invitra Cord Blood Stem Cells
Characterization Report: Invitra CBSC™
Good Tissue Bank Standards of Practice
Your patient’s extracted tooth is not a waste!
Role of Platelet rich fibrin in wound healing: A critical review
Gum Drop Technique: Minimally Invasive Soft-Tissue Platelet-Rich Fibrin Grafting for Marginal Soft-Tissue Recession
2018—the year of 3-D printing in the dental office?
International Journal of Growth Factors and Stem Cells in Dentistry
Injectable-platelet rich fibrin using the low
speed centrifugation concept

LSCC (Low Speed Centrifugation Concept)
2017 fujioka kobayashi

Live Surgery Photo